N@N

Bernstein Liebhard LLP Announces Investigation Of Chiesi Farmaceutici SpA's Going Private Offer

^{Published on 2013-02-21 07:00:57 - Market Wire}
 

Cornerstone Therapeutics Inc. Shareholder Alert: Bernstein Liebhard LLP Announces Investigation Of Chiesi... -- NEW YORK, Feb. 21, 2013 /PRNewswire/ --

[ ]

[ Download image ]

NEW YORK, Feb. 21, 2013 /PRNewswire/ -- Bernstein Liebhard LLP is investigating whether the Board of Directors of Cornerstone Therapeutics Inc. ("Cornerstone Therapeutics" or the "Company") (NASDAQ: [ CRTX ]) and Chiesi Farmaceutici SpA ("Chiesi"), the majority shareholder of Cornerstone Therapeutics, are breaching their fiduciary duties to the Company's shareholders in connection with an offer by Chiesi, to take the Company private.

(Logo: [ http://photos.prnewswire.com/prnh/20120202/MM47134LOGO ] )

Under the terms of the offer, Cornerstone Therapeutics shareholders will receive between $6.40 and $6.70 in cash for each share of common stock they own.  The investigation is focused on whether Chiesi Farmaceutici SpA's offer undervalues the Company's shares.

If you are interested in discussing your rights as a Cornerstone Therapeutics shareholder and/or have information relating to the matter, please contact U. Seth Ottensoser at (877) 779-1414 or [ Ottensoser@bernlieb.com ].

Bernstein Liebhard has pursued hundreds of securities, [ consumer ] and shareholder rights cases and recovered over $3 billion for its clients.  It has been named to The National Law Journal's "Plaintiffs' Hot List" in each of the last ten years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
(877) 779-1414
[ www.bernlieb.com ]

ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP.  The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.  The lawyer responsible for this advertisement in the State of Connecticut is Michael S. Bigin.  Prior results do not guarantee or predict a similar outcome with respect to any future matter.

SOURCE Bernstein Liebhard LLP